Workflow
Here's why Pfizer (PFE) stock is surging
PFEPfizer(PFE) Finbold·2024-12-17 17:22

Pfizer (NYSE: PFE) shares rose nearly 3% to 25.98inpremarkettradingonDecember17afterthepharmaceuticalgiantreleasedits2025financialguidance. Whiletheoutlookpaintedamixedpicture,investorsentimentleanedpositive,drivenbyanoptimisticearningsforecastthatsignalsprogressinPfizer’songoingturnaroundefforts.Atpresstime,Pfizerstockwastradingat25.98 in premarket trading on December 17 after the pharmaceutical giant released its 2025 financial guidance. While the outlook painted a mixed picture, investor sentiment leaned positive, driven by an optimistic earnings forecast that signals progress in Pfizer’s ongoing turnaround efforts.At press time, Pfizer stock was trading at 26.30, marking a 2.7% gain for the day, with the monthly chart showing a 3% increase. Despite these gains, Pfizer remains down 11% ...